LEX Diagnostics is creating a step-change improvement to the molecular diagnostics available to primary care.
Our system is a true PCR diagnostic, with the accuracy that implies, but we have pushed back the limitations of existing point-of-care systems which inhibit their use in primary care.
- Faster: The sample-to-result time is short enough to fit with the existing workflows in primary care and so offers a near instant result. In our view this means 5-7 minutes.
- Cheaper: The cost is low enough to displace antigen testing in primary care.
- Safer: The swab inserts directly into the LEX cartridge making infection control much stronger.
Our first product will address the COVID-19 pandemic with a SARS-CoV-2 / flu A/B differential diagnostic and later disease targets will include variant specific SARS-CoV-2 mini panels, RSV, Strep A, parainfluenza and measles .
The underlying thermocycling technology innovations are also applicable to wider sample types. This allows us to enter markets requiring the use of blood, stool and STI related samples in the longer term.